Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexagliflozin placebo-controlled phase 3 study in adults with type 2 diabetes and elevated cardiovascular risk
NL-OMON47856Phase 3Active, not recruiting
- Sponsor
- Theracos, Inc.
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Bexagliflozin with Placebo (2 arms). Started Sep 2016; status: active, not recruiting.
02
Drugs
bexagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON47856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47856.